Description

Overview

AOD-9604 is a synthetic peptide research compound identified in scientific literature as a defined fragment corresponding to amino acids 177–191 of the human growth hormone sequence. Its characterization and evaluation are confined exclusively to controlled laboratory research environments, where it is examined as a discrete molecular entity within experimental and analytical frameworks. Published references involving AOD-9604 limit its investigation to non-clinical research settings, including peptide structure analysis, molecular interaction studies, analytical method development, and experimental modeling related to lipid-associated biochemical pathways. All documented findings remain restricted to laboratory-based evaluation and analytical observation. No representations or claims are made regarding therapeutic intent, clinical relevance, or suitability for human or veterinary use. This material is supplied solely for research and analytical purposes under strictly non-clinical conditions.

Biochemical Characteristics

AOD-9604 is a synthetic peptide research compound referenced in scientific literature as a defined fragment corresponding to amino acids 177–191 of the human growth hormone sequence. Its characterization is limited to molecular-level investigation conducted exclusively within controlled laboratory research environments. Research involving AOD-9604 centers on biochemical and structural analysis, including peptide sequence verification, molecular stability assessment, and investigational modeling of lipid-associated signaling pathways at the molecular level. All documented evaluations are confined to non-clinical experimental frameworks and analytical research contexts, with no application beyond laboratory-based investigation.

Molecular Class: Synthetic peptide research compound

Net Content: 5 mg

Purity: ≥99% (research-grade)

Physical State: Lyophilized powder

Intended Use: Laboratory research only

Research Applications

In published scientific and supplier literature, AOD-9604 is described as a synthetic peptide research compound examined within experimental research frameworks under strictly non-clinical laboratory conditions. Its role in research is limited to analytical and observational study conducted exclusively within controlled experimental systems. Analytical investigation of peptide structure and sequence characteristics associated with defined fragments of the human growth hormone sequence in experimental model systems Molecular interaction modeling related to lipid-associated biochemical pathways examined under controlled laboratory conditions Evaluation of peptide stability and molecular integrity within non-clinical analytical environments Analytical reference use in chromatographic method development, peptide characterization, and identity verification Purity assessment and stability evaluation within regulated laboratory research workflows All referenced applications are strictly confined to controlled laboratory research and non-clinical experimental use. No claims are made regarding biological outcomes, clinical relevance, or applicability outside of investigational research settings.

Pathway / Mechanistic Context

Within experimental research literature, AOD-9604 is discussed in relation to molecular pathways associated with defined peptide fragments derived from the human growth hormone sequence. These pathways are examined at the molecular and biochemical level within controlled laboratory systems to support investigation of peptide–pathway interactions and lipid-associated signaling models under experimental conditions. Additional mechanistic references explore molecular frameworks related to lipid metabolism–associated signaling pathways and peptide-mediated molecular interactions evaluated through analytical and observational research approaches. All mechanistic discussions remain exploratory in nature and are strictly limited to non-clinical laboratory research environments. No interpretations extend beyond analytical research contexts, and no claims are made regarding biological outcomes, clinical relevance, or applicability outside controlled experimental systems.

Preclinical Research Summary

Preclinical research references discuss AOD-9604–related observations derived from controlled experimental model systems used to examine molecular characteristics associated with defined peptide fragments of the human growth hormone sequence. These investigations focus on laboratory-based analysis of peptide structure, molecular stability, and pathway-associated signaling markers evaluated within non-clinical research frameworks. Additional studies describe exploratory evaluation of lipid-associated biochemical signaling models and peptide-related molecular interactions examined under controlled experimental conditions. All reported observations remain confined to preclinical experimental systems and are presented solely for investigational and analytical purposes. No findings suggest clinical relevance, therapeutic intent, or suitability for human or veterinary use. All references are limited strictly to controlled laboratory research environments.

Form & Analytical Testing

AOD-9604 is supplied as a research-grade synthetic peptide material presented in lyophilized powder form. The material is manufactured under controlled laboratory conditions to support consistency, stability, and molecular integrity during analytical handling and evaluation. Identity and purity verification are performed using established analytical techniques standard to peptide characterization. These include chromatographic separation methods and mass spectrometric analysis to confirm peptide identity, molecular integrity, and purity specifications. All testing is conducted exclusively to support material characterization within controlled laboratory research settings.

Referenced Citations

Ng FM, et al. “Metabolic effects of a synthetic lipolytic domain derived from human growth hormone (AOD-9604).” Journal of Endocrinology, 2000. Heffernan M, et al. “Effects of human growth hormone and its lipolytic fragment (AOD-9604) on lipid metabolism.” Endocrinology, 2001. Serrano-Rios M, et al. “Growth hormone fragments and lipid metabolism: experimental observations.” International Journal of Obesity. Human Growth Hormone – C-terminal Fragment Overview (177–191). UniProt Knowledgebase (UniProtKB).

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

RUO Disclaimer

All products available on this website are supplied exclusively for in vitro laboratory research purposes. In vitro research refers to experimental studies conducted outside of living organisms within controlled laboratory environments. These materials are not drugs, medications, dietary supplements, or medical products and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any use beyond controlled laboratory research, including introduction into humans or animals, is strictly prohibited. For Laboratory Research Use Only (RUO). Not for human use, medical use, diagnostic use, or veterinary use.